As the United States looks to fulfill its semiconductor needs on its own, Arizona is fast emerging as a base for the domestic industry’s revival. View the Fall 2021 issue of TechConnect Magazine to read articles from TGen, Avnet, Arizona Commerce Authority, Northern Arizona University, Arizona State University, UArizona and more.
The Translational Genomics Research Institute (TGen) has received a grant from Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC), one of the largest manufacturers of computer chips, to sustain the fight against COVID-19. The funds will advance TGen’s genomic sequencing of the virus, which enables the identification of specific variants.
The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine—an herb used in China for centuries to treat joint pain, swelling and fever—is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer.
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has appointed Dr. Sunil Sharma as physician-in-chief following a nearly three-decade career that spans the areas of research, drug and clinical trial development. Sharma succeeds Dr. Daniel D. Von Hoff, a leading expert in pancreatic cancer who was instrumental in developing key clinical and research programs at TGen.
On the heels of a study showing how cancer can be precisely detected by a liquid biopsy blood test created by the Translational Genomics Research Institute (TGen), a new $2.1 million federal grant will enable TGen and Mayo Clinic researchers to fine-tune the system in clinical trials.